USFDA nod to Pfizer Braftovi Combination Regimen for BRAF V600E-Mutant Metastatic Colorectal Cancer Ruchika Sharma21 Dec 2024 2:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) in combination with...
Chemoradiotherapy may be safely omitted in some patients with locally advanced rectal cancer: PROSPECT trial Medha Baranwal11 Jun 2023 8:00 PM ISTUSA: Findings from the PROSPECT trial have shown preoperative FOLFOX to be non-inferior to preoperative chemoradiotherapy for disease-free survival...
Medical Bulletin 30/November/2022 Dr. Nandita Mohan30 Nov 2022 1:15 PM ISTHere are the top medical news for the day:Study highlights association between oral bacteria and diseasesPrevious studies have demonstrated clear...
Cancer-fighting nanoparticles co-delivering a chemotherapy drug & immunotherapy Dr. Nandita Mohan30 Nov 2022 9:15 AM ISTChemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse. This process involves a lipid called...
Combination chemotherapy improves survival in patients with pancreatic cancer Dr. Nandita Mohan16 July 2022 9:00 AM ISTIn a study of patients with borderline resectable pancreatic cancer, combination chemotherapy with modified FOLFIRINOX before surgery increased...
Rare case of Fluorouracil -Induced Hyperpigmentation Hina Zahid27 Jan 2020 6:00 PM ISTDr Jordan K. Schaefer and Dr Nithya Ramnath at the University of Michigan, Ann Arbor, MI have reported a rare case of Fluorouracil-Induced...
FDA approves first emergency treatment for chemotherapy overdose savita thakur thakur14 Dec 2015 11:49 AM ISTThe U.S. Food and Drug Administration approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an...
